KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Change in Inventory (2016 - 2026)

Abbott Laboratories' Change in Inventory history spans 18 years, with the latest figure at $420.0 million for Q1 2026.

  • On a quarterly basis, Change in Inventory rose 64.71% to $420.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$30.0 million, a 69.07% increase, with the full-year FY2025 number at -$195.0 million, down 436.21% from a year prior.
  • Change in Inventory hit $420.0 million in Q1 2026 for Abbott Laboratories, up from -$234.0 million in the prior quarter.
  • Over the last five years, Change in Inventory for ABT hit a ceiling of $554.0 million in Q1 2022 and a floor of -$295.0 million in Q4 2023.
  • Historically, Change in Inventory has averaged $113.4 million across 5 years, with a median of $189.0 million in 2022.
  • Biggest five-year swings in Change in Inventory: skyrocketed 9420.0% in 2022 and later plummeted 256.08% in 2023.
  • Tracing ABT's Change in Inventory over 5 years: stood at $189.0 million in 2022, then plummeted by 256.08% to -$295.0 million in 2023, then rose by 20.34% to -$235.0 million in 2024, then rose by 0.43% to -$234.0 million in 2025, then skyrocketed by 279.49% to $420.0 million in 2026.
  • Business Quant data shows Change in Inventory for ABT at $420.0 million in Q1 2026, -$234.0 million in Q4 2025, and -$213.0 million in Q3 2025.